Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

US Army
UBS
QuintilesIMS
Cerilliant
Harvard Business School
Federal Trade Commission
Argus Health
Farmers Insurance
Fuji

Generated: April 27, 2018

DrugPatentWatch Database Preview

Details for Patent: 6,126,971

« Back to Dashboard

Summary for Patent: 6,126,971
Title: Stable oral CI-981 formulation and process for preparing same
Abstract:An oral pharmaceutical composition is provided for treating hypercholestereolemia or hyperlipidemia containing an advantageous formulation for stabilizing the HMG-CoA coenzyme A inhibitor, CI-981 Hemi-Calcium, of formula (IA) ##STR1## with effective amounts of calcium carbonate. A method for preparing a CI-981 stabilizing composition is described.
Inventor(s): Mills; Nancy (Mt. Arlington, NJ), Muhammad; Nouman A. (Long Valley, NJ), Weiss; Jay (East Brunswick, NJ), Nesbitt; Russell U. (Somerville, NJ)
Assignee: Warner-Lambert Company (Morris Plains, NJ)
Application Number:08/886,982
Patent Claim Types:
see list of patent claims
Use; Composition; Compound; Dosage form;

Drugs Protected by US Patent 6,126,971

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Patent Submitted

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

International Family Members for US Patent 6,126,971

Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration
Austria 178794 ➤ Try a Free Trial
Canada 2150372 ➤ Try a Free Trial
Cyprus 2128 ➤ Try a Free Trial
Germany 69324504 ➤ Try a Free Trial
Country Document Number Estimated Expiration Supplementary Protection Certificate SPC Country SPC Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Queensland Health
Harvard Business School
Accenture
Cipla
Argus Health
Medtronic
Healthtrust
Fish and Richardson
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.